EGElena García-Redondo

Elena García-Redondo

*This is an algorithmically generated author record based on publicly available information.

Elena García-Redondo has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lived Experiences, Disease Management and Expectations in a Nursing-Led Psoriasis Unit: A Qualitative Study

    by Elena Violeta Iborra-Palau, Elena García-Redondo, Carlos Blasco-García, Raquel Alabau-Dasi

    Background: Psoriasis is a chronic systemic disease affecting over 60 million people. While phototherapy is effective, its demanding schedule imposes a significant treatment burden. This study explores the lived experiences and healthcare expectations of patients in specialized nursing-led phototherapy units. Methods: A descriptive phenomenological study was conducted (2019–2022) with 72 participants at a Spanish tertiary hospital. Data from semi-structured interviews were analyzed using inductive thematic content analysis. Results: Nine subtopics emerged within four main thematic areas: (1) a gap between psychological awareness and low knowledge of systemic comorbidities; (2) psychological stress as the primary disease trigger; (3) an adherence-stress cycle causing biographical disruption; and (4) a collective demand for a permanent nursing referent to overcome systemic barriers. Conclusions: Phototherapy’s clinical efficacy is often undermined by its logistical rigor. Achieving skin clearance is insufficient if biographical and systemic gaps remain. Integrated care models, led by specialized dermatology nurses, are essential to provide clinical navigation and support beyond conventional skin treatment.


  • Open Access

    Lived Experiences, Disease Management and Expectations in a Nursing-Led Psoriasis Unit: A Qualitative Study

    by Elena Violeta Iborra-Palau, Elena García-Redondo, Carlos Blasco-García, Raquel Alabau-Dasi

    Background: Psoriasis is a chronic, systemic and immune-mediated disease that affects over 60 million people worldwide. Although phototherapy is a safe and effective treatment, its demanding thrice-weekly clinical regimen imposes a significant treatment burden that can disrupt the patient’s life narratives. Despite its clinical importance, little is known about how patients navigate the logistical and emotional complexities of this therapy within specialised nursing-led units. Objective: To explore the lived experiences, disease management strategies, and healthcare expectations of patients with psoriasis undergoing phototherapy. Methods: A descriptive phenomenological design was adopted. Between 2019 and 2022, purposive and exhaustive sampling was used to recruit 72 participants receiving treatment at a specialised nursing-led phototherapy unit in a tertiary hospital in Spain. Data were collected through semi-structured interviews and analysed using inductive thematic content analysis supported by NVivo 12 Pro. Results: Eleven subtopics emerged within four main thematic areas: (1) Knowledge about the disease and treatment options: A striking dichotomy exists between a well-recognised psychological burden and a persistent lack of awareness regarding systemic physical comorbidities and biological therapies; (2) Triggers of the disease and flare-ups: Psychological stress was identified as the primary driver of disease activity, overshadowing secondary external factors; (3) Functional and logistical stressors: The rigorous frequency of sessions creates an "adherence-stress cycle," where the effort to maintain therapeutic continuity paradoxically generates the stress that exacerbates clinical flares, leading to profound biographical disruption and a perceived incapacity to fulfil professional and family roles; (4) Healthcare expectations and systemic barriers: Participants identified diagnostic delays and inequities in the financing of supportive care, manifesting as a collective demand for a permanent professional nursing referent to act as an anchor for integrated care. Conclusions: Phototherapy functions as a "double-edged sword" where clinical efficacy frequently conflicts with the logistical rigour of the treatment. Clinical skin clearance is insufficient if the biographical and systemic gaps remain unaddressed. This investigation advocates for a paradigm shift toward integrated care models where specialised dermatology nurses provide the necessary clinical navigation to support patients "beyond the surface" of the disease.